American Samoa vs Bangladesh: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
American Samoa
0.4%
in 2024
Bangladesh
0.4%
in 2024
American Samoa rank
74th
Bangladesh rank
74th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- American Samoa
- Bangladesh
How they compare
American Samoa currently reports 0.4% against 0.4% in Bangladesh, a difference of 0.0%.
Across all 10 years both countries report, Bangladesh has been ahead every year.
American Samoa ranks 74th and Bangladesh ranks 74th of 246 countries.
Bangladesh has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | American Samoa | Bangladesh | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.4% | 0.7% | 0.2% | Bangladesh |
| 2020s | 0.5% | 0.5% | 0.1% | Bangladesh |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, American Samoa or Bangladesh?
- American Samoa, at 0.4% against 0.4% in Bangladesh as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between American Samoa and Bangladesh?
- 0.0%, with American Samoa ahead.
- How many years of comparable data are there for American Samoa and Bangladesh?
- 10 years are reported by both, from 2015 to 2024.
- How do American Samoa and Bangladesh rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- American Samoa ranks 74th and Bangladesh ranks 74th of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.